home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Colon Cancer Stem Cells

  December, 6 2006 9:10
your information resource in human molecular genetics
A specific type of colon cancer cell capable of initiating tumour growth in mice is identified and characterized in a pair of related papers to be published online in Nature. Both papers lend support to the theory that, within a tumour, only a subset of cells - cancer stem cells - are responsible for tumour formation and maintenance.

John Dick and colleagues studied tumour growth by implanting human colon cancer cells under the kidney capsule of mice with a deficient immune system. They report that only a small population of these cells was able to initiate tumour growth and that these cells are found in the subset of colon cancer cells that express the cell surface protein CD133. This protein has previously been implicated as a marker for brain and prostate cancer stem cells. Ruggero De Maria and colleagues show that human colon cancer cells expressing CD133 also cause tumour growth when injected under the skin of immunodeficient mice.

These studies demonstrate that a small population of colon cancer cells, distinct from those that make up the bulk of a tumour, initiate tumour growth. The authors propose that the approaches used to identify and characterize these cells might aid future attempts to understand the processes involved in colon cancer and develop novel therapeutic strategies to treat the disease.

Author contact:

John Dick (University Health Network, Toronto, Canada)
E-mail: jdick@uhnres.utoronto.ca

Ruggero De Maria (Istituto Superiore di Sanità, Rome, Italy)
E-mail: rdemaria@tin.it

Abstracts available online:
Article 1.
Article 2.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.